The joint InFLAMES Flagship of the University of Turku and Åbo Akademi University has invited Professor Tero Aittokallio as a Visiting Professor. Aittokallio will give his first InFLAMES Visiting Professor Lecture on Monday October 28th.
His group has expertise in integrating multi-omics profiling and clinical information from cancer patients using mathematical and statistical approaches such as machine learning and network modeling.
– The medical aim is to optimize treatment outcomes for individual patients using maximally predictive models and minimal biomarker signatures that enable real-time and cost-effective routine diagnostics and prognosis, Aittokallio explains.
His group has expertise in integrating multi-omics profiling and clinical information from cancer patients using mathematical and statistical approaches such as machine learning and network modeling.
– The medical aim is to optimize treatment outcomes for individual patients using maximally predictive models and minimal biomarker signatures that enable real-time and cost-effective routine diagnostics and prognosis, Aittokallio explains.
Aittokallio believes that combining functional, molecular and genomic profiling information is critical for next-generation precision medicine applications, where integrative modeling and clever use of big data will pinpoint effective and selective targets for personalized therapies.
A total of 14 visiting professorships have now been awarded in the InFLAMES Flagship. The visiting professors come to Turku each year according to a separately arranged schedule. Their key responsibilities include student mentoring and lectures especially in the InFLAMES doctoral programme.
Aittokallio will give a Visiting Professor Lecture on Friday October 28th. The topic of his lecture is “Predictive modelling of treatment responses in hematological malignancies”. The talk will take place at 3 pm in Lauren 2 auditorium, Medisiina D building, Kiinanmyllynkatu 10, Turku.
InFLAMES Flagship is a joint initiative of University of Turku and Åbo Akademi University, Finland. The goal of the Flagship is to integrate the immunological and immunology-related research activities to develop and exploit new diagnostic and therapeutic tools for personalised medicine. InFLAMES in funded by Academy of Finland.